Understanding GLP-1 Medications
Contact Hours: 2
Pharmacology Hours: 2
What's included?
Course Overview
This course provides a comprehensive overview of glucagon-like peptide-1 (GLP-1) receptor agonists and their expanding role in managing obesity and type 2 diabetes mellitus (T2DM). Participants will explore how these medications function, evaluate the most common adverse effects and review the best practices for administration and patient monitoring. This course emphasizes strategies for effective interprofessional collaboration to maximize treatment outcomes. The course integrates foundational knowledge on obesity, including body mass index (BMI) parameters and the importance of lifestyle interventions—to offer a provider-based perspective on combining pharmacology with diet, exercise, and multidisciplinary support.
Course Outline
- Introduction
- From Insulin to GLP-1: Tracing the Path of Diabetes Innovation
- GLP-1 Case Study
- List of the most common GLP-1 agonists include:
- Indications for Use
- Mechanism of Action
- Absorption
- Distribution
- Metabolism
- Excretion
- GLP-1 Agonist Use Overview
- Dosing Frequency Overview of Common GLP-1 Receptor Agonists
- Semaglutide
- Tirzepatide
- Risk & Benefits
- Contraindications and Precautions
- Pancreatitis Risks
- Compounded Semaglutide Warnings
- Overdose Considerations
- Outcomes
- Conclusion
Course Outcomes
After completing this course, the learner will rate a 4 out of 5 on the Likert Scale for their ability to:
- Discuss how GLP-1 receptor agonists influence insulin release, glucagon inhibition, gastric emptying, and appetite regulation to improve glycemic control and promote weight loss.
- Recognize the most common gastrointestinal and systemic side effects of GLP-1 receptor agonists and discuss appropriate interventions or precautions to mitigate these issues.
- Learners will identify treatment plans to improve adherence, address barriers, and enhance overall patient care in obesity and T2DM management.
Accreditations and Approvals
- American Nurses Credentialing Center (ANCC) (P0614)
- California Board of Registered Nursing (CEP 17418)
- Kentucky Board of Nursing (7-0090)
- Louisiana State Board of Nursing (58)
- Florida Board of Nursing (50-23983)
- Delaware Board of Nursing (DE-24-010127)
- Alabama Board of Nursing (#ABNP1577)
- Iowa Board of Nursing (#393)
- Kansas Board of Nursing (LT0340-0325)
Approved by the Board of Nursing in every state, you can complete your RN, LVN, and APRN CEUs with confidence.
Accreditation Statement
Nursing CE Central LLC is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
It will take the average learner 120 minutes to complete and awards 2 contact hours of continuing education.
Written For
- Registered Nurses (RN)
- Advanced Practice Registered Nurses (APRN)
- Licensed Practical Nurses (LPN/LVN)
Requirements for Completion
- Enrollment in the course by the learner
- Read and learn all course materials
- Complete the course evaluation
- Attest and testify learning of the course materials
Disclosure of Relevant Financial Relationships
Nursing CE Central nor any of the authors, planners, content experts, or any contributors have any relevant financial relationships with ineligible companies to disclose.
